On July 13th, RIBOLIFE-B (06938) spent HKD 930.12 million to repurchase 186,000 H shares.
Rebibo Biology-B (06938) announced that the company repurchased a total of 186,000 H shares on the open market on July 13, 2026, with a total cost of 9.3012 million Hong Kong dollars. All repurchased H shares are held as treasury shares.
RIBOLIFE-B(06938) announced that the company repurchased a total of 186,000 H shares on the open market on July 13, 2026, at a total cost of 9.3012 million Hong Kong dollars. All repurchased H shares are held as treasury shares.
Related Articles
WENYE GROUP (01802): Huang Zhijiang appointed as authorized representative and company secretary
Kaisa Health (00876): Yang Feng appointed as an executive director
Chongqing Sokon Industry Group Stock(09927): Controlling shareholder Sokon Holdings plans to increase holding of company's A shares.
WENYE GROUP (01802): Huang Zhijiang appointed as authorized representative and company secretary
Kaisa Health (00876): Yang Feng appointed as an executive director
Chongqing Sokon Industry Group Stock(09927): Controlling shareholder Sokon Holdings plans to increase holding of company's A shares.
RECOMMEND
